IL101325A0 - Pyridazinone acetic acids - Google Patents

Pyridazinone acetic acids

Info

Publication number
IL101325A0
IL101325A0 IL101325A IL10132592A IL101325A0 IL 101325 A0 IL101325 A0 IL 101325A0 IL 101325 A IL101325 A IL 101325A IL 10132592 A IL10132592 A IL 10132592A IL 101325 A0 IL101325 A0 IL 101325A0
Authority
IL
Israel
Prior art keywords
acetic acids
pyridazinone acetic
pyridazinone
acids
acetic
Prior art date
Application number
IL101325A
Other languages
English (en)
Original Assignee
Pfizer
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pfizer filed Critical Pfizer
Publication of IL101325A0 publication Critical patent/IL101325A0/xx

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D413/00Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
    • C07D413/02Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings
    • C07D413/06Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00Drugs for skeletal disorders
    • A61P19/06Antigout agents, e.g. antihyperuricemic or uricosuric agents
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00Drugs for disorders of the metabolism
    • A61P3/08Drugs for disorders of the metabolism for glucose homeostasis
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00Drugs for disorders of the metabolism
    • A61P3/08Drugs for disorders of the metabolism for glucose homeostasis
    • A61P3/10Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D237/00Heterocyclic compounds containing 1,2-diazine or hydrogenated 1,2-diazine rings
    • C07D237/02Heterocyclic compounds containing 1,2-diazine or hydrogenated 1,2-diazine rings not condensed with other rings
    • C07D237/06Heterocyclic compounds containing 1,2-diazine or hydrogenated 1,2-diazine rings not condensed with other rings having three double bonds between ring members or between ring members and non-ring members
    • C07D237/10Heterocyclic compounds containing 1,2-diazine or hydrogenated 1,2-diazine rings not condensed with other rings having three double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D237/14Oxygen atoms
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D237/00Heterocyclic compounds containing 1,2-diazine or hydrogenated 1,2-diazine rings
    • C07D237/26Heterocyclic compounds containing 1,2-diazine or hydrogenated 1,2-diazine rings condensed with carbocyclic rings or ring systems
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D237/00Heterocyclic compounds containing 1,2-diazine or hydrogenated 1,2-diazine rings
    • C07D237/26Heterocyclic compounds containing 1,2-diazine or hydrogenated 1,2-diazine rings condensed with carbocyclic rings or ring systems
    • C07D237/30Phthalazines
    • C07D237/32Phthalazines with oxygen atoms directly attached to carbon atoms of the nitrogen-containing ring
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D417/00Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
    • C07D417/02Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings
    • C07D417/06Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
IL101325A 1991-03-28 1992-03-22 Pyridazinone acetic acids IL101325A0 (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US67691991A 1991-03-28 1991-03-28

Publications (1)

Publication Number Publication Date
IL101325A0 true IL101325A0 (en) 1992-11-15

Family

ID=24716565

Family Applications (1)

Application Number Title Priority Date Filing Date
IL101325A IL101325A0 (en) 1991-03-28 1992-03-22 Pyridazinone acetic acids

Country Status (19)

Country Link
EP (1) EP0582643A1 (xx)
JP (1) JPH06500793A (xx)
CN (1) CN1065269A (xx)
AU (1) AU658887B2 (xx)
BR (1) BR9205810A (xx)
CA (1) CA2107104A1 (xx)
CZ (1) CZ387092A3 (xx)
DE (1) DE9290035U1 (xx)
FI (1) FI934222A0 (xx)
HU (1) HUT67836A (xx)
IE (1) IE920979A1 (xx)
IL (1) IL101325A0 (xx)
MX (1) MX9201414A (xx)
NZ (1) NZ242152A (xx)
PT (1) PT100301A (xx)
TW (1) TW207998B (xx)
WO (1) WO1992017446A2 (xx)
YU (1) YU30392A (xx)
ZA (1) ZA922238B (xx)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ES2240657T3 (es) 2001-02-28 2005-10-16 Pfizer Products Inc. Compuestos de sulfonilpiridazinona utiles como inhibidores de aldosa reductasa.
SE0100873D0 (sv) * 2001-03-13 2001-03-13 Astrazeneca Ab Method of treatment
DK1491540T3 (da) 2001-03-30 2007-03-26 Pfizer Prod Inc Intermediater, der er anvendelige til syntese af pyridazinon-aldosereduktase inhibitorer
AU761191B2 (en) * 2001-05-24 2003-05-29 Pfizer Products Inc. Therapies for tissue damage resulting from ischemia
US7572910B2 (en) 2003-02-20 2009-08-11 Pfizer, Inc. Pyridazinone aldose reductase inhibitors
CN111617072B (zh) * 2019-02-27 2023-06-20 苏州凯祥生物科技有限公司 一种高尿酸血症药物组合物及用于治疗高尿酸血症的药物

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPH0676391B2 (ja) * 1987-06-09 1994-09-28 フアイザー・インコーポレイテツド ベンゾチアゾール等の複素環側鎖を有するオキソフタラジニル酢酸類の製造方法
FR2647676A1 (fr) * 1989-06-05 1990-12-07 Union Pharma Scient Appl Nouveaux derives de pyridazinone, leurs procedes de preparation, medicaments les contenant, utiles notamment comme inhibiteurs de l'aldose reductase

Also Published As

Publication number Publication date
CN1065269A (zh) 1992-10-14
EP0582643A1 (en) 1994-02-16
BR9205810A (pt) 1994-06-28
CA2107104A1 (en) 1992-09-29
WO1992017446A3 (en) 1992-11-26
CZ387092A3 (en) 1994-02-16
NZ242152A (en) 1994-07-26
FI934222A (fi) 1993-09-27
IE920979A1 (en) 1992-10-07
PT100301A (pt) 1993-06-30
AU658887B2 (en) 1995-05-04
YU30392A (sh) 1994-11-15
TW207998B (xx) 1993-06-21
ZA922238B (en) 1993-09-27
JPH06500793A (ja) 1994-01-27
HU9302728D0 (en) 1993-12-28
DE9290035U1 (de) 1993-11-18
FI934222A0 (fi) 1993-09-27
HUT67836A (en) 1995-05-29
MX9201414A (es) 1992-10-01
WO1992017446A2 (en) 1992-10-15
AU1779692A (en) 1992-11-02

Similar Documents

Publication Publication Date Title
IL102813A0 (en) Imidazolyl-alkenoic acids
AP9200447A0 (en) Acetic acid derivatives
ZA937474B (en) Quinolonecarboxylic acids
ZA932790B (en) Acetic acid derivatives
ZA923279B (en) Substituted carboxylic acid derivatives
EP0563238A4 (en) Imidazolyl-alkenoic acids
KR960009420B1 (en) Catheter
HU9202817D0 (en) Bicyclical carboxylic acid derivatives
ZA928979B (en) Novel aminoalkanephosphinic acids and salts thereof
AU1432092A (en) Quinoxaline phosphono-amino acids
AU3166093A (en) Induction heater
IL109310A0 (en) Alkyl substituted nitroimidazole acetic acids
IL101325A0 (en) Pyridazinone acetic acids
ZA913132B (en) Carboxylic acid derivatives
AU640328B2 (en) Sulfimidoperoxycarboxylic acids
GB9213420D0 (en) Aromatic carboxylic acids
GB9117221D0 (en) Heaters
HU9301754D0 (en) Substituted benzothiazolyl-phenyl acetic acid derivatives and quinooxalyl-methoxi ones
NO933446D0 (no) Pyridazinon-eddiksyrer
IL103938A0 (en) Novel phenylsulfonylacrylate ester derivatives
IE901193L (en) 5-alkylquinolone carboxylic acids
ZA93377B (en) Acetic acid derivatives
ZA928768B (en) Acetic acid derivatives.
EP0499080A3 (en) Aminoacid derivatibes
ZA949397B (en) Acetic acid derivative